SECHI, Leonardo Alberto
 Distribuzione geografica
Continente #
NA - Nord America 22.674
EU - Europa 7.987
AS - Asia 4.146
SA - Sud America 754
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 11
Totale 35.667
Nazione #
US - Stati Uniti d'America 22.467
UA - Ucraina 2.600
SG - Singapore 2.126
DE - Germania 1.286
IT - Italia 1.249
CN - Cina 1.159
FI - Finlandia 968
BR - Brasile 692
RU - Federazione Russa 634
IE - Irlanda 438
SE - Svezia 329
TR - Turchia 278
KR - Corea 236
CA - Canada 174
GB - Regno Unito 139
FR - Francia 72
VN - Vietnam 68
BE - Belgio 60
IN - India 54
HK - Hong Kong 51
AT - Austria 45
NL - Olanda 38
IR - Iran 32
CZ - Repubblica Ceca 29
EU - Europa 24
TG - Togo 23
MX - Messico 22
AR - Argentina 19
BD - Bangladesh 19
PL - Polonia 18
ES - Italia 16
ZA - Sudafrica 16
IQ - Iraq 15
JP - Giappone 15
AU - Australia 10
PK - Pakistan 10
DK - Danimarca 9
IL - Israele 9
UZ - Uzbekistan 9
AZ - Azerbaigian 8
CL - Cile 8
EG - Egitto 8
MA - Marocco 8
VE - Venezuela 8
CO - Colombia 7
CH - Svizzera 6
EC - Ecuador 6
PE - Perù 6
PH - Filippine 6
TW - Taiwan 6
AM - Armenia 5
KZ - Kazakistan 5
RO - Romania 5
RS - Serbia 5
TN - Tunisia 5
AL - Albania 4
EE - Estonia 4
ID - Indonesia 4
LT - Lituania 4
LV - Lettonia 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
GR - Grecia 3
JO - Giordania 3
KE - Kenya 3
NP - Nepal 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BG - Bulgaria 2
BO - Bolivia 2
BT - Bhutan 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MD - Moldavia 2
ME - Montenegro 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
GE - Georgia 1
GL - Groenlandia 1
GY - Guiana 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
Totale 35.657
Città #
Woodbridge 2.604
Fairfield 2.543
Jacksonville 1.860
Ann Arbor 1.741
Chandler 1.482
Houston 1.474
Ashburn 1.257
Singapore 1.138
Wilmington 1.106
Dearborn 1.061
Seattle 989
Cambridge 886
Boardman 618
Beijing 495
Princeton 469
Dublin 434
Izmir 247
Seoul 221
Munich 217
Udine 200
San Diego 181
Ottawa 141
Helsinki 140
Des Moines 112
Ogden 101
Norwalk 91
Milan 90
Hefei 88
Nanjing 76
Kunming 69
San Mateo 68
Dong Ket 66
Falls Church 59
Los Angeles 56
Brussels 51
Rome 51
Hong Kong 49
São Paulo 49
Redmond 48
Guangzhou 47
New York 46
Trieste 45
Nuremberg 37
Grafing 31
Santa Clara 28
Shanghai 27
Vienna 27
Düsseldorf 26
Jinan 24
Brno 23
Lomé 23
Washington 23
Nanchang 21
Rio de Janeiro 21
San Francisco 21
Frankfurt am Main 19
Leawood 18
Belo Horizonte 17
Brooklyn 16
Fuzhou 16
Indiana 16
Warsaw 15
Council Bluffs 14
Hebei 14
London 14
Phoenix 14
Saint Petersburg 14
Zanjan 14
Brasília 13
Mcallen 13
Toronto 13
Turku 13
Wuhan 13
Andover 12
Boston 12
Xi'an 12
Istanbul 11
Pignone 11
Baotou 10
Bologna 10
Hangzhou 10
Lauterbourg 10
Paris 10
Porto Alegre 10
Secaucus 10
Tokyo 10
Amsterdam 9
Codroipo 9
Henderson 9
Hyderabad 9
Mexico City 9
Moscow 9
Nanning 9
Portsmouth 9
Ribeirão Preto 9
Tavagnacco 9
Turin 9
Venice 9
Xian 9
Zhengzhou 9
Totale 23.628
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 244
Alcohol Intake and Arterial Hypertension: Retelling of a Multifaceted Story 209
Abnormalities of glucose metabolism and cardiovascular events in patients with hypertensive nephrosclerosis and mild renal failure 197
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 170
Primary aldosteronism: cardiovascular, renal and metabolic implications 158
Aldosterone and the heart: from basic research to clinical evidence 156
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 152
Abnormalities of insulin receptors in spontaneously hypertensive rats 151
Methacrylates allergy in a professional beautician 148
Aldosterone and Left Ventricular Remodeling 148
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 144
Venous thrombosis and acute renal failure in paroxysmal nocturnal haemoglobinuria. 142
BLUNTED EFFECT OF ANP ON HEMATOCRIT AND PLASMA-VOLUME IN STREPTOZOTOCIN-INDUCED DIABETES-MELLITUS IN RATS 141
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data 140
Nickel and sulfites food allergy in patients with angioedema associated with ACE inhibitor use 137
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism 137
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 135
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 134
SERUM-INSULIN, INSULIN SENSITIVITY, AND ERYTHROCYTE SODIUM-METABOLISM IN NORMOTENSIVE AND ESSENTIAL HYPERTENSIVE SUBJECTS WITH AND WITHOUT OVERWEIGHT 133
The emergent cardiovascular risk factors and organ damage in arterial hypertension 133
Abnormalities of glucose metabolism in patients with early renal failure 131
Aldosterone and the heart: still an unresolved issue? 131
Effects of angiotensin II (ANG II) infusion on insulin receptor binding and gene expression in the kidney of normal and diabetic rats 131
Effects of alcohol withdrawal on blood pressure in hypertensive heavy drinkers 130
Aldosterone, Organ Damage, and Dietary Salt 130
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 129
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 128
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 127
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS ASSOCIATED WITH HEPATITIS-C INFECTION WITH NO EVIDENCE OF LIVER-DISEASE 126
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance 126
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 126
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 125
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 125
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 125
Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal 125
Treatment of primary aldosteronism and organ protection 125
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 124
Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II) 124
Prohypertensive effect of insulin: possible role of the sympathetic system 123
Predictors of target-organ damage in hypertension: role of lipoprotein(a) [Lp(a)] and apo(a) isoforms 123
Intrahepatic cholestatis of pregnancy; a in vivo model of the hepatic clearance of adiponectin 123
Elevated serum CA 19-9 in hepatic actinomycosis 123
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 123
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 123
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 122
Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats 122
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes 121
Benzodiazepines: an old class of new antihypertensive drugs? 120
Kidney in primary aldosteronism: a key determinant of treatment outcome 119
Correlazioni clinico-prognostiche del diabete mellito in pazienti con arteriopatia degli arti inferiori sintomatica:dati preliminari 118
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 117
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 117
Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: Results from the MINISAL-SIIA study program 117
Spontaneous restoration of sinus rhythm after cardiac surgery 117
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 117
Ontogenic expression of renal and hepatic angiotensin II receptor genes in the rat 116
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial 116
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 116
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 116
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 115
DISTRIBUTION OF ANGIOTENSIN-II RECEPTOR SUBTYPES IN RAT AND HUMAN KIDNEY 114
URODILATIN BINDS TO AND ACTIVATES RENAL RECEPTORS FOR ATRIAL-NATRIURETIC-PEPTIDE 114
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells. 114
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 114
Potassium-sparing diuretics in hypertension 113
Benign familial macrocytosis 113
Salt, hypertension, and cardiovascular disease 113
Cardiovascular outcomes in patients with primary aldosteronism after treatment 113
Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance 113
Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects 112
ANTIHYPERTENSIVE EFFECT OF INSULIN REDUCTION IN DIABETIC-HYPERTENSIVE PATIENTS 112
Receptors for atrial natriuretic peptide are decreased in the kidney of rats with streptozotocin-induced diabetes mellitus 112
Renal function in primary aldosteronism 112
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 112
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients 111
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 111
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 111
CHARACTERIZATION OF ANGIOTENSIN-II RECEPTOR SUBTYPES IN THE RAT-KIDNEY AND HEART USING THE NONPEPTIDE ANTAGONISTS DUP-753 AND PD-123-177 110
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study 110
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 110
Insulin receptors and renal sodium handling in hypertensive fructose-fed rats 109
The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension 109
Renin, angiotenisnogen, and angiotensin II type I receptor mRNA levels after unilateral nephrectomy 109
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 109
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 109
Autonomic dysfunction in hyperadrenergic orthostatic hypotension 109
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 108
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 108
Omega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic Fatty Liver Disease: Are They So Good? 108
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 107
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 107
The SPARTACUS Trial: Controversies and Unresolved Issues 107
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 107
THE CARDIAC RENIN-ANGIOTENSIN SYSTEM IN STZ-INDUCED DIABETES 106
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 106
Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design. 105
ACUTE EFFECTS OF FUROSEMIDE ON BLOOD-PRESSURE IN FUNCTIONALLY ANEPHRIC, VOLUME-EXPANDED RATS 105
INSULINEMIA AND BLOOD-PRESSURE - RELATIONSHIPS IN PATIENTS WITH PRIMARY AND SECONDARY HYPERTENSION, AND WITH OR WITHOUT GLUCOSE-METABOLISM IMPAIRMENT 104
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 104
EXPRESSION OF AT2-RECEPTORS IN THE DEVELOPING RAT FETUS 103
Totale 12.404
Categoria #
all - tutte 148.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.539


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020822 0 0 0 0 0 0 0 0 0 0 178 644
2020/20215.176 147 556 166 674 162 681 240 604 892 182 624 248
2021/20223.594 136 421 153 263 100 149 201 212 55 585 692 627
2022/20233.748 539 211 75 421 328 1.103 14 238 520 76 112 111
2023/20241.221 182 92 92 56 234 129 38 32 151 66 20 129
2024/20256.080 171 618 248 244 164 487 504 563 868 636 1.577 0
Totale 36.717